Indian Journal of Sleep Medicine

Register      Login

VOLUME 1 , ISSUE 3 ( July-September, 2006 ) > List of Articles

EDITORIAL

Obstructive Sleep Apnea, Metabolic Syndrome, and Implications For Cardio-Vascular Diseases

J. C. Suri

Citation Information : Suri JC. Obstructive Sleep Apnea, Metabolic Syndrome, and Implications For Cardio-Vascular Diseases. Indian Sleep Med 2006; 1 (3):121-124.

DOI: 10.5005/ijsm-1-3-121

License: CC BY-SA 4.0

Published Online: 01-07-2006

Copyright Statement:  Copyright © 2006; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Young T, Palta M, Dempsey J et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230–5.
  2. Shahar E, Whitney C, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163(1):19–25.
  3. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease JAMA. 2003;290:1906-1914.
  4. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976;37:269–82.
  5. Larssen B, Svardstudd K,Welin L, et al. Abdominal adipose tissue distribution, obesity and the risk of cardiovascular diseases and death: 13 year follow up of the men born in 1913.BMJ 1984;288:1401–4.
  6. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.
  7. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285: 2846– 2497.
  8. Reaven G. Metabolic syndrome. Pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286-288.
  9. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829–1836.
  10. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746–1752.
  11. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–1384.
  12. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997;99:106–109.
  13. Bao G, Metreveli N, Fletcher EC. Acute and chronic blood pressure response to recurrent acoustic arousal in rats. Am J Hypertens 1999;12:504–510.
  14. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000;18:679–685.
  15. Logan AG, Tkacova R, Tisler A, Leung RS, Fitzgerald FS, Bradley TD. High prevalence of obstructive sleep apnea in refractory hypertension. J Hypertension 2001. (In press)
  16. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD. Effects of continuous positive airway pressure on blood pressure in refractory hypertensive patients with sleep apnea. J Hypertens 2001. (In press).
  17. Levinson PD, McGarvey ST, Carlisle CC, et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993;103:1336–42.
  18. Grunstein RR, Wilcox I, Yang TS, et al. Snoring and sleep apnea in men: interaction with central obesity and hypertension. Int J Obesity 1993;17:533–40
  19. Strohl KP, Novak RD, Singer W, et al. Insulin levels, blood pressure and sleep apnea. Sleep 1994;17:614–8.
  20. Brooks BA, Cistulli PA, Borkman M, et al. Effect of nasal continuous positive airway pressure treatment on insulin sensitivity in patients with type II diabetes and obstructive sleep apnea. J Clin Endocrinol Metab 1994;79:1681–5.
  21. Obstructive sleep apnoea syndrome impairs inslulin sensitivity independently of anthropometric variables. Clin Endocrinol (oxf). 2003 Sep;59(3):374-9.
  22. Harsch IA, Hahn EG, Konturek PC. Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit, 2005 Mar;11 (3):RA70-5.
  23. Ip M, Lam B, Ng M et al. Obstructive sleep apnoea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670–6.
  24. Punjabi N, Sorkin J, Katzel L et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165(5):677–82.
  25. Harsch IA, Pour Schahin S, Radespiel-Troger M et al. CPAP treatment rapidly improves insulin sensitivity in patients with OSAS. Am. J. Respir. Crit. Care Med. 2003.
  26. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897–1904.
  27. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 1988;6:S529–S531.
  28. Narkiewicz K, Masahiko Kato, Bradley G. Phillips,; Catherine A. Pesek, DO; Diane E. Davison, RN, MA; Virend K. Somers. Nocturnal Continuous Positive Airway Pressure Decreases Daytime Sympathetic Traffic in Obstructive Sleep Apnea Circulation. 1999;100:2332-2335.
  29. Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000;16:648–652.
  30. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995;108:625–630.
  31. Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, Mishima M, Kuno K. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153: 1972–1976.
  32. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999;26:74–84.
  33. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162:566– 570.
  34. Teramota S, Yamamota H, Ouchi Y. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome [letter]. Circulation 2003;107, E40.
  35. Alexandros N, Vgontzas, Dimitris A, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85,1151-1158.
  36. Wilcox I, mc Namara SG, Collins FL et al. “Syndrome Z”. the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax. 1998:53 (Suppl 3) S25-S28.
  37. Coughlin S., Lynn Mawdsley, Julie A. Mugarza, Peter M. A. Calverley, John P. H. Wilding. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. European Heart Journal (2004) 25, 735–741.
  38. Mooe T, Franklin KA, Holmstrom K et al. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am. J. Respir. Crit. Care Med. 2001;164:1910-1913.
  39. Peker Y, hedner J, Kraiczi H et al. Respiratory disturbance index: an independent predictor of mortality I coronary artery disease. Am. J. Respir. Crit. Care Med. 2000;162:81-86.
  40. Shiina K, Tomiyama H, Takata Y, Usui Y et al. concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbataes the cardiovascular risk: a sleep clinic cohort study. Hypertens REs. 2006 Jun;29 (6):433-41.
  41. Olivier Millerona, Remy Pilli_erea, Arlette Foucherb, Florence de Roquefeuila, Philippe Aegerterc, Guillaume Jondeaua, Bernadette G. Raffestinb, Olivier Dubourga Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. European Heart Journal 2004; 25: 728–734
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.